CARILLON TOWER ADVISERS, INC. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 270 filers reported holding NOVOCURE LTD in Q1 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.

Quarter-by-quarter ownership
CARILLON TOWER ADVISERS, INC. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q4 2020$53,754,000
+520.0%
310,642
+298.8%
0.33%
+181.9%
Q3 2020$8,670,000
-100.0%
77,894
-86.4%
0.12%
-68.0%
Q1 2020$36,949,314,000
-23.4%
572,6800.0%0.36%
+12.4%
Q4 2019$48,259,744,000
+112590.6%
572,6800.0%0.32%
+8.1%
Q3 2019$42,825,000572,6800.30%
Other shareholders
NOVOCURE LTD shareholders Q1 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$39,681,00020.12%
HARTLINE INVESTMENT CORP/ 330,672$27,866,0005.97%
MORGAN JESS S & CO INC 52,889$4,457,0004.37%
Darsana Capital Partners LP 1,350,000$113,765,0003.88%
Rhenman & Partners Asset Management AB 350,000$29,495,0003.23%
COURAGE CAPITAL MANAGEMENT LLC 10,000$843,0002.55%
Taylor Frigon Capital Management LLC 38,073$3,208,0002.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 35,500$2,991,0001.08%
Granite Investment Partners, LLC 261,315$22,021,0001.04%
Nicholas Investment Partners, LP 85,835$7,233,0000.74%
View complete list of NOVOCURE LTD shareholders